OMX Nordic 40
2.507,01
PKT
+17,22
PKT
+0,69
%
Werbung
Analysen zu OMX Nordic 40-Werten
Datum | Rating | Analyst | |
---|---|---|---|
12.06.18 | AstraZeneca Outperform | Credit Suisse Group | |
11.06.18 | Volvo (B) buy | Citigroup Corp. | |
11.06.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
08.06.18 | Novo Nordisk buy | UBS AG | |
07.06.18 | Volvo (B) Sell | UBS AG | |
06.06.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
06.06.18 | AstraZeneca buy | Deutsche Bank AG | |
31.05.18 | Novo Nordisk Reduce | HSBC | |
30.05.18 | Novo Nordisk overweight | Morgan Stanley | |
30.05.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
30.05.18 | Novo Nordisk buy | UBS AG | |
30.05.18 | Novo Nordisk buy | Deutsche Bank AG | |
30.05.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
29.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
29.05.18 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
28.05.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
25.05.18 | AstraZeneca Outperform | Credit Suisse Group | |
24.05.18 | AstraZeneca Hold | S&P Capital IQ | |
22.05.18 | AstraZeneca Equal-Weight | Morgan Stanley | |
22.05.18 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
22.05.18 | AstraZeneca overweight | Barclays Capital | |
22.05.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
22.05.18 | AstraZeneca buy | Deutsche Bank AG | |
18.05.18 | AstraZeneca Neutral | UBS AG | |
18.05.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
18.05.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
15.05.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
14.05.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
14.05.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
14.05.18 | AstraZeneca buy | Jefferies & Company Inc. | |
11.05.18 | AstraZeneca overweight | Barclays Capital | |
08.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
08.05.18 | Nokia overweight | JP Morgan Chase & Co. | |
04.05.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
03.05.18 | Novo Nordisk Verkaufen | DZ BANK | |
03.05.18 | Novo Nordisk buy | Deutsche Bank AG | |
03.05.18 | Novo Nordisk buy | UBS AG | |
03.05.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
03.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
03.05.18 | Novo Nordisk Neutral | Credit Suisse Group |